ABSI
Price
$2.57
Change
-$0.05 (-1.91%)
Updated
Jun 30 closing price
Capitalization
326.55M
49 days until earnings call
SANA
Price
$2.73
Change
-$0.08 (-2.85%)
Updated
Jun 30 closing price
Capitalization
614.64M
30 days until earnings call
Interact to see
Advertisement

ABSI vs SANA

Header iconABSI vs SANA Comparison
Open Charts ABSI vs SANABanner chart's image
Absci
Price$2.57
Change-$0.05 (-1.91%)
Volume$4.25M
Capitalization326.55M
Sana Biotechnology
Price$2.73
Change-$0.08 (-2.85%)
Volume$4.8M
Capitalization614.64M
ABSI vs SANA Comparison Chart in %
Loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SANA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSI vs. SANA commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a StrongBuy and SANA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (ABSI: $2.57 vs. SANA: $2.73)
Brand notoriety: ABSI and SANA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 137% vs. SANA: 129%
Market capitalization -- ABSI: $326.55M vs. SANA: $614.64M
ABSI [@Biotechnology] is valued at $326.55M. SANA’s [@Biotechnology] market capitalization is $614.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileSANA’s FA Score has 0 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • SANA’s FA Score: 0 green, 5 red.
According to our system of comparison, SANA is a better buy in the long-term than ABSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 2 TA indicator(s) are bullish while SANA’s TA Score has 4 bullish TA indicator(s).

  • ABSI’s TA Score: 2 bullish, 6 bearish.
  • SANA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SANA is a better buy in the short-term than ABSI.

Price Growth

ABSI (@Biotechnology) experienced а -6.88% price change this week, while SANA (@Biotechnology) price change was +5.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.71%. For the same industry, the average monthly price growth was +31.92%, and the average quarterly price growth was +6.10%.

Reported Earning Dates

ABSI is expected to report earnings on Aug 19, 2025.

SANA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+3.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SANA($615M) has a higher market cap than ABSI($327M). SANA YTD gains are higher at: 67.485 vs. ABSI (-1.908). ABSI has higher annual earnings (EBITDA): -93.91M vs. SANA (-195.34M). ABSI has more cash in the bank: 134M vs. SANA (105M). ABSI has less debt than SANA: ABSI (8.92M) vs SANA (91.3M). ABSI has higher revenues than SANA: ABSI (4.82M) vs SANA (0).
ABSISANAABSI / SANA
Capitalization327M615M53%
EBITDA-93.91M-195.34M48%
Gain YTD-1.90867.485-3%
P/E RatioN/AN/A-
Revenue4.82M0-
Total Cash134M105M128%
Total Debt8.92M91.3M10%
TECHNICAL ANALYSIS
Technical Analysis
ABSISANA
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 12 days ago
89%
Bullish Trend 26 days ago
76%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SANA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JEMSX35.37N/A
N/A
JPMorgan Emerging Markets Equity I
JRSSX12.28N/A
N/A
JH Adaptive Risk Mgd U.S. Eq S
GCASX43.51N/A
N/A
Gabelli Small Cap Growth A
MFMPX16.53N/A
N/A
Morgan Stanley Inst Next Gen Em Mkts A
EMECX11.90N/A
N/A
Ashmore Emerging Markets Equity C

SANA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SANA has been loosely correlated with VIR. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if SANA jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SANA
1D Price
Change %
SANA100%
-4.88%
VIR - SANA
64%
Loosely correlated
-2.51%
CPRX - SANA
43%
Loosely correlated
-0.37%
AXON - SANA
43%
Loosely correlated
+1.14%
GBIO - SANA
39%
Loosely correlated
+6.56%
ABSI - SANA
39%
Loosely correlated
-1.91%
More